Conteduca, V; Wetterskog, D; Sharabiani, M-T-A; Grande, E; Fernández-Pérez, M-P; Jayaram, A; Salvi, S; Castellano, D; Romanel, A; Lolli, C; Casadio, V; Gurioli, G; Amadori, D; Font, A; Vazquez-Estevez, S; González-del-Alba, A; Mellado, B; Fernández-Calvo, O; Méndez-Vidal, M-J; Climent, M-A; Duran, I; Gallardo, E; Rodríguez, A; Santander, C; Saez, M-I; Puente, J; Tandefelt, D-Gasi; Wingate, A; Dearnaley, D; Demichelis, F; De-Giorgi, U; González-Billalabeitia, Enrique; Attard, G
(OXFORD UNIV PRESS, 2017-07)
BACKGROUND: There is an urgent need to identify biomarkers to guide personalized therapy in castration-resistant prostate cancer (CRPC). We aimed to clinically qualify androgen receptor (AR) gene status measurement in ...